show episodes
 
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen each month as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you make change? Why should I care?" to a new biopharma executive and hear insights on this rapidly changing field.
 
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, a long-time industry consultant who has advised biopharma leaders on licensing, mergers and acquisitions, pricing and market access, commercialization and go-to-market strategies, each episode explores the challenges and considerations involved wi ...
 
One-on-one with medical innovators Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collec ...
 
BioPharma EH&S Podcast. The latest discussion on potent compound safety, occupational toxicology, industrial hygiene, and compliance management software. To submit questions or comments to the podcast email affygility@gmail.com or call our listener voicemail line at 206-984-3214.
 
Dedicated to improvement, the life sciences industry has a mandate to improve the quality and safety of human life. Every day, innovations and breakthroughs happen around the world. With rapid changes happening, it’s no wonder that awareness and perspectives are crucial for healthcare professionals. This helps them focus on patients and play their roles effectively and efficiently. If you want to stay ahead and get informed, join Gaurav Kandhari here on Life Sciences Value Share. He shares a ...
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, former ...
 
Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years. DDW has grown as a quarterly business review of drug discovery and development, and now we've created this podcast to allow you to listen to our articles on the go. In our journal and this podcast, we cover topics surrounding: drug discovery; drug development; business; chemistry; enabling technologies; informa ...
 
Your Brain On... is a podcast by Learning and Development professionals for Learning and Development professionals. Every day, Salience Learning combines the science of learning with expertise in the business of science to help solve the biopharma industry's most complex business challenges. Listen as hosts Karen Foster and Krista Gerhard discuss the latest in cognitive science and learning strategies as they relate to the ever-evolving healthcare industry. In other words: Your Brain On... g ...
 
Join Nancy Donohoo’s bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy’s guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innov ...
 
Patentable Leadership Podcast provides leadership insights and innovation tools for executives and mid-career professionals in the STEM (science, technology, engineering, mathematics), biotech and biopharma industries. Listeners will get equipped on how to retool their leadership and effect continuous reinvention in order to achieve continuous growth and create more impact in business and life. The podcast holds conversations about leadership and innovation featuring interviews with business ...
 
The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter. The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impa ...
 
Every medicine in your pharmacy has a human story behind it. Real people doing real work and living real lives. We all have romantic ideas about scientists working late into the evening or doctors dropping everything to answer a phone call about a patient. You can almost envision the moment when one of those researchers finally solves an intellectual puzzle and leaps into action. Their eyes go from an empty stare to an alert laser-like focus. They sit a bit taller and start to read frantical ...
 
Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, an ...
 
Loading …
show series
 
Eric Ostertag, M.D., Ph.D., wanted to launch a biotech. When University of Pennsylvania department heads said no to a licensing deal for lack of a CEO, Dr. Ostertag convinced them he could run the company. Many bold moves later, Dr. Ostertag is founder and CEO at Poseida Therapeutics, a company that's doing things never seen before in the field of …
 
The demands of the healthcare system are ever-increasing because of evolving diseases and medications. The oncology commercial sector must also undergo changes if it hopes to cope with such significant shifts. In this first part of a series, Gaurav Kandhari taps industry leader and pharma executive Michelle Werner to talk about the right way to edu…
 
Cervical cancer is one of the leading causes of cancer morbidity and mortality in women worldwide. While widespread use of HPV vaccination is dramatically reducing the number of women developing the disease where vaccination is common, the global number of new cases is projected to climb over the next decade.Treatment options until now have been li…
 
On this week’s podcast: One of the more interesting and important trends in medtech in recent years is the emergence of robotic assisted surgery. But as RAS procedures increase, so do the chances of something going wrong. And when it does, who’s to blame? The robot or the surgeon?Medtech Insight articles addressing topics discussed in this episode:…
 
This is the latest episode of the free DDW podcast: “Opportunities to improve drug discovery systems”. It covers two articles written for Volume 22, Issue 1 – Winter 2020/21 of the Drug Discovery World Magazine. The first article is titled “Precision control of protein release to reconfigure bioprocessing and cell-based assays”, where the authors D…
 
Judy Chou, Ph.D. was a big-pharma MVP. She earned her academic stripes in the hallowed halls of Yale, the Max Planck Institute, and Harvard Medical School before taking on principal scientist roles at AbbVie, Pfizer, and Genentech. That experience parlayed into SVP positions at Tanvex, Medvation, back to Pfizer, and on to Bayer, where she was most …
 
Rapid development of mRNA-based COVID-19 vaccines has drawn global attention. But could DNA-based vaccines work better in the long run?Recent emergency use authorization for Zydus Cadila’s DNA-based COVID-19 vaccine made headlines worldwide, previewing what’s possible. Now, join BioWorld Insider as we take a closer look at this type of vaccine with…
 
In this edition of Device Week, Medtech Insight’s Marion Webb gives a summary of this year’s American Academy Of Orthopedics annual meeting, where she discusses new products from a range of companies, and interesting meetings with executives. UK-based reporter Barnaby Pickering sheds light on Owlstone Medical’s new diagnostic method, and Editor Ree…
 
What if you had 30 years of longitudinal data, from thousands of HCPs across 30 specialties, on how and why health care practitioners prescribe therapies, and where and how they prefer to receive information on those therapies – or even how a major event, like a pandemic, impacted those behaviors? You would have powerful insights that point the way…
 
This is the final part of our three-part conversation with prolific author, researcher, and professor Barbara Oakley, Ph.D. Karen, Krista, and Barbara discuss how the patterns and pathways picked up during past learning experiences influence how our brains react to future learning challenges when building new skills.…
 
The biologic therapy market is crowded, and judging by the recent parade of IPOs, competition for investment, mindshare, talent, and ultimately share of market is only getting stiffer. On this week's episode of the Business of Biotech, our friend and biotech business guru Allan Shaw joins us for a foundational conversation on creating competitive d…
 
This is the latest episode of the free DDW podcast, “Putting virology back on the map: the fight against Covid-19”. It covers two articles written for Volume 22, Issue 1 – Winter 2020/21 of the Drug Discovery World Magazine. The first article is a case study titled “New technology in COVID research may accelerate vaccines”, and the second is called…
 
Aruvant Chief Technology Officer Palani Palaniappan, Ph.D. joins the Business of Biotech with special guest Tony Khoury, EVP at Project Farma to discuss recent advances in gene therapy manufacturing. We cover the role of artificial intelligence in the discovery of AAV capsids that can avoid the immune system, the growth of non-viral vectors, the sc…
 
COVID-19's impact on clinical trials has been broad and varied. Recruiting disruptions, protocol changes and logistical challenges have forced both investigators and regulators to adapt. As the pandemic continues to shape how trials are run, key stakeholders are responding with new ideas to keep drug candidates on track. Join us as we talk to Lauri…
 
Davinderpreet Mangat, David Dahan, and Ellie Davenport discuss new developments in the diffuse large B-cell lymphoma (DLBCL) and melanoma space. Topics covered include:• DLBCL – CAR-T therapies: 1:23• DLBCL – Polivy: 12:40• Melanoma – Lifileucel: 20:20• Melanoma – Keytruda: 27:25Supporting links:https://service.datamonitorhealthcare.com/hkc/disease…
 
In this week’s podcast, Marion Webb discusses the future of robotic surgery and Barnaby Pickering breaks down the trauma fixation device market.The archive of Device Week and the rest of Informa Pharma Intelligence’s podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn, Spotify Pod…
 
John Couse, Vice President of Scientific Services at Taconic Biosciences discusses the benefits of a robust colony management solution/partner in the drug discovery success; how it can enable companies to scale through resource management and create efficiencies. Couse has extensive knowledge of colony managements solutions and outlines the benefit…
 
In this podcast Dr. Joanna Hawryluk discusses automating the cell culture workflow and explains the importance of cell culture workflow in the drug discovery process and how it can be improved thanks to technological advances. Hawryluk talks us through the cell culture workflow and its relevance within the drug discovery process focussing on the ar…
 
This is part two of our three-part conversation with prolific author, researcher, and professor Barbara Oakley, Ph.D. Karen, Krista, and Barbara discuss how the patterns and pathways picked up during past learning experiences influence how our brains react to future learning challenges when building new skills.…
 
Dr. Ian Walters' company, Portage Biotech, is focused on addressing the 75% of cancer patients who show no, or limited, response to existing therapies such as checkpoint inhibitors. Leading that charge are the company's invariant natural killer T cell agonists, designed to activate the innate and adaptive immune system, as well as a growing portfol…
 
In both the US and EU, we are seeing a push for large-scale cosmetics regulation, with the Personal Care Products Safety Act and European Green Deal respectively. For HBW Insight executive editor Ryan Nelson, this raises questions about what and whom it will serve ultimately, particularly when compared with the burdens being levied on industry and …
 
On this week’s podcast we discuss the US agency’s final regulation on the intended use of products, which device makers must follow beginning on 1 September.Medtech Insight articles addressing topics discussed in this episode:• FDA Widens Scope In Considering Evidence For Off-Label UseBy Informa
 
This week, the US Food and Drug administration approved the first COVID-19 vaccine. But will this help accelerate the vaccination effort? The US Surgeon General gave a public warning recently: "Health misinformation is an urgent threat to public health. It can cause confusion, sow mistrust, and undermine public health efforts, including our ongoing…
 
In this month’s podcast, Medtech Insight's Reed Miller and Marion Webb provide a recap of our digital health coverage in July, including start-ups that grabbed new funding, product launches and regulatory clearances. Listen to the podcast via the player below:Medtech Insight articles addressing topics discussed in this episode:Exec Chat: New CEO of…
 
Everyone in the business is looking for breakthroughs, but only a select few win breakthrough therapy designation from the FDA. Under the guidance of Ira Gupta, M.D. and Shanthi Ganeshan, Ph.D, GSK has a few BTDs under its belt. Dr. Gupta is VP of Medicine Development at GSK and Dr. Ganeshan is formerly VP of Global Regulatory Affairs there, having…
 
About a third of all human cancers are driven by mutations in RAS genes. Many RAS mutations make cells resistant to a lot of approved cancer therapies. Some members of the RAS gene family encode proteins that have a key role in cell signaling. When those genes are mutated, cells grow uncontrollably and evade death signals. So far, blocking RAS gene…
 
In this week’s podcast, Medtech Insight's US Commercial manager Reed Miller provides an overview of Abbott’s Amplatzer Amulet, which was approved by the US FDA for preventing thrombus embolization in patients with nonvalvular atrial fibrillation. Managing editor Marion Webb discusses Zimmer Biomet’s FDA clearance of its Rosa robotic surgery platfor…
 
This episode covers two narrated articles written for DDW and is read aloud by Megan Thomas, both of which were published in Volume 22, Issue 1 – Winter 2020/21 of Drug Discovery World. The first article is titled, “Streamlining gene therapy manufacturing will help products reach more patients”, and was written by Akash Bhattacharya, the Senior App…
 
“Pharmaceutical companies sometimes have a bad rap of being, you know, big, bad pharmacy. But I learned that the patient or the people I am working with right now are just as passionate and just as dedicated to the patient community as I am.” Amy Grover, Director of Patient Advocacy at Catalyst Pharmaceuticals Amy Grover is a familiar face to the r…
 
Prolific author, researcher and professor Barbara Oakley, Ph.D., joins Karen and Krista to discuss how the patterns and pathways picked up during past learning experiences influence how our brains react to future learning challenges when building new skills. This is part one of a three-part series.By Salience Learning
 
Maintaining therapeutic integrity through cryopreservation and super cold supply chains have challenged, and continue to vex, biologics producers. On this episode of the Business of Biotech, Celyad Oncology Head of Cell Therapy Manufacturing Thomas Lequertier shares best practices for the cryopreservation of cell therapies while minimizing cell deg…
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login